Soybean protein-derived hydrolysate affects blood pressure in spontaneously hypertensive rats

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The aim of this study was to investigate the inhibitory activity of angioten-sin-converting enzyme (ACE) and antihypertensive effects of soybean protein hydrolysate in spontaneously hypertensive rats (SHRs). The inhibitory activities against ACE with an IC50 of the peptidic fraction were 0.82 (casein), 0.73 (soybean protein isolate), and 0.48 mg/mL (soybean acid-precipitated protein), respectively. Peptic hydrolysate containing 1% NaCl was added to the SHRs' feed (5% of each protein hydrolysate). Systolic blood pressure of the soybean protein hydrolysate-supplemented groups were significantly lower than that of the casein hydrolysate-supplemented group in the study period. These data suggested that soybean protein hydrolysate may retard the development of hypertension in SHRs by its ACE inhibitory effect in vivo.

Original languageEnglish
Pages (from-to)61-73
Number of pages13
JournalJournal of Food Biochemistry
Volume28
Issue number1
Publication statusPublished - Feb 2004

ASJC Scopus subject areas

  • Food Science
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry

Fingerprint Dive into the research topics of 'Soybean protein-derived hydrolysate affects blood pressure in spontaneously hypertensive rats'. Together they form a unique fingerprint.

  • Cite this